scispace - formally typeset
M

Mark D. Pegram

Researcher at Stanford University

Publications -  245
Citations -  45881

Mark D. Pegram is an academic researcher from Stanford University. The author has contributed to research in topics: Breast cancer & Trastuzumab. The author has an hindex of 59, co-authored 228 publications receiving 41167 citations. Previous affiliations of Mark D. Pegram include University of Miami & UCLA Medical Center.

Papers
More filters
Journal ArticleDOI

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

TL;DR: The addition of trastuzumab to chemotherapy was associated with a longer time to disease progression, a higher rate of objective response, a longer duration of response, and a lower rate of death at 1 year.
Journal ArticleDOI

Comprehensive molecular portraits of human breast tumours

Daniel C. Koboldt, +355 more
- 04 Oct 2012 - 
TL;DR: The ability to integrate information across platforms provided key insights into previously defined gene expression subtypes and demonstrated the existence of four main breast cancer classes when combining data from five platforms, each of which shows significant molecular heterogeneity.
Journal ArticleDOI

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

TL;DR: T-DM1 significantly prolonged progression-free and overall survival with less toxicity than lapatinib plus capecitabine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.